Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
June 25, 2009
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer
Y Mohri, T Mohri, W Wei, et al.
Magnetic Resonance in Chemistry : MRC
|
October 1, 2009
Fast targeted multidimensional NMR metabolomics of colorectal cancer
C Ludwig, D G Ward, A Martin, et al.
Blood Cells, Molecules & Diseases
|
February 28, 2012
Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy
A Finkenstedt, A Widschwendter, C G Brasse-Lagnel, et al.
British Journal of Cancer
|
January 13, 2006
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
D G Ward, Y Cheng, G N'Kontchou, et al.
British Journal of Cancer
|
June 7, 2006
Identification of serum biomarkers for colon cancer by proteomic analysis
D G Ward, N Suggett, Y Cheng, et al.
British Journal of Cancer
|
April 18, 2013
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
N J Shimwell, R T Bryan, W Wei, et al.
Omics : a Journal of Integrative Biology
|
October 8, 2005
Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study
G D Stentiford, M R Viant, D G Ward, et al.
British Journal of Cancer
|
February 27, 2015
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
R T Bryan, H L Regan, S J Pirrie, et al.
British Journal of Cancer
|
September 13, 2012
Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas
N J Shimwell, D G Ward, Y Mohri, et al.
British Journal of Cancer
|
December 3, 2013
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
R T Bryan, N J Shimwell, W Wei, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
June 25, 2009
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer
Y Mohri, T Mohri, W Wei, et al.
Magnetic Resonance in Chemistry : MRC
|
October 1, 2009
Fast targeted multidimensional NMR metabolomics of colorectal cancer
C Ludwig, D G Ward, A Martin, et al.
Blood Cells, Molecules & Diseases
|
February 28, 2012
Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy
A Finkenstedt, A Widschwendter, C G Brasse-Lagnel, et al.
British Journal of Cancer
|
January 13, 2006
Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis
D G Ward, Y Cheng, G N'Kontchou, et al.
British Journal of Cancer
|
June 7, 2006
Identification of serum biomarkers for colon cancer by proteomic analysis
D G Ward, N Suggett, Y Cheng, et al.
British Journal of Cancer
|
April 18, 2013
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
N J Shimwell, R T Bryan, W Wei, et al.
Omics : a Journal of Integrative Biology
|
October 8, 2005
Liver tumors in wild flatfish: a histopathological, proteomic, and metabolomic study
G D Stentiford, M R Viant, D G Ward, et al.
British Journal of Cancer
|
February 27, 2015
Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
R T Bryan, H L Regan, S J Pirrie, et al.
British Journal of Cancer
|
September 13, 2012
Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas
N J Shimwell, D G Ward, Y Mohri, et al.
British Journal of Cancer
|
December 3, 2013
Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
R T Bryan, N J Shimwell, W Wei, et al.
Page
of 6